ARS Pharmaceuticals Statistics
Total Valuation
SPRY has a market cap or net worth of $833.15 million. The enterprise value is $808.35 million.
Important Dates
The next estimated earnings date is Wednesday, August 12, 2026, before market open.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SPRY has 99.30 million shares outstanding. The number of shares has increased by 1.59% in one year.
| Current Share Class | 99.30M |
| Shares Outstanding | 99.30M |
| Shares Change (YoY) | +1.59% |
| Shares Change (QoQ) | +0.27% |
| Owned by Insiders (%) | 6.15% |
| Owned by Institutions (%) | 54.69% |
| Float | 42.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.47 |
| Forward PS | 5.13 |
| PB Ratio | 13.83 |
| P/TBV Ratio | 17.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.94, with a Debt / Equity ratio of 2.79.
| Current Ratio | 4.94 |
| Quick Ratio | 4.64 |
| Debt / Equity | 2.79 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -40.16 |
Financial Efficiency
Return on equity (ROE) is -136.40% and return on invested capital (ROIC) is -584.01%.
| Return on Equity (ROE) | -136.40% |
| Return on Assets (ROA) | -41.15% |
| Return on Invested Capital (ROIC) | -584.01% |
| Return on Capital Employed (ROCE) | -85.06% |
| Weighted Average Cost of Capital (WACC) | 7.69% |
| Revenue Per Employee | $622,553 |
| Profits Per Employee | -$1.25M |
| Employee Count | 159 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 5.00 |
Taxes
| Income Tax | -80,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -54.07% in the last 52 weeks. The beta is 0.83, so SPRY's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | -54.07% |
| 50-Day Moving Average | 8.71 |
| 200-Day Moving Average | 9.35 |
| Relative Strength Index (RSI) | 43.41 |
| Average Volume (20 Days) | 1,920,771 |
Short Selling Information
The latest short interest is 23.09 million, so 23.25% of the outstanding shares have been sold short.
| Short Interest | 23.09M |
| Short Previous Month | 25.50M |
| Short % of Shares Out | 23.25% |
| Short % of Float | 54.40% |
| Short Ratio (days to cover) | 13.84 |
Income Statement
In the last 12 months, SPRY had revenue of $98.99 million and -$197.98 million in losses. Loss per share was -$2.00.
| Revenue | 98.99M |
| Gross Profit | 58.81M |
| Operating Income | -202.42M |
| Pretax Income | -198.06M |
| Net Income | -197.98M |
| EBITDA | -200.93M |
| EBIT | -202.42M |
| Loss Per Share | -$2.00 |
Full Income StatementBalance Sheet
The company has $200.97 million in cash and $171.20 million in debt, giving a net cash position of $29.77 million or $0.30 per share.
| Cash & Cash Equivalents | 200.97M |
| Total Debt | 171.20M |
| Net Cash | 29.77M |
| Net Cash Per Share | $0.30 |
| Equity (Book Value) | 61.31M |
| Book Value Per Share | 0.62 |
| Working Capital | 195.62M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$175.07 million and capital expenditures -$248,000, giving a free cash flow of -$175.32 million.
| Operating Cash Flow | -175.07M |
| Capital Expenditures | -248,000 |
| Depreciation & Amortization | 1.48M |
| Net Borrowing | 96.26M |
| Free Cash Flow | -175.32M |
| FCF Per Share | -$1.77 |
Full Cash Flow StatementMargins
Gross margin is 59.41%, with operating and profit margins of -204.49% and -200.00%.
| Gross Margin | 59.41% |
| Operating Margin | -204.49% |
| Pretax Margin | -200.08% |
| Profit Margin | -200.00% |
| EBITDA Margin | -202.99% |
| EBIT Margin | -204.49% |
| FCF Margin | n/a |
Dividends & Yields
SPRY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.59% |
| Shareholder Yield | -1.59% |
| Earnings Yield | -23.62% |
| FCF Yield | -20.92% |
Analyst Forecast
The average price target for SPRY is $28.40, which is 238.50% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $28.40 |
| Price Target Difference | 238.50% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 68.42% |
| EPS Growth Forecast (3Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SPRY has an Altman Z-Score of 0.25 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.25 |
| Piotroski F-Score | 1 |